Our runners up for Litigator of the Week include Kirkland & Ellis partner Devora Allon. She scored for Teva in an antitrust class action arising out of a patent litigation settlement concerning generic versions of anti-seizure drug Lamictal.
Allon successfully petitioned the Third Circuit to grant Teva’s interlocutory appeal challenging the district court’s class certification decision. This is the first time the Third Circuit has questioned direct purchaser plaintiff class certification in reverse payment cases since its landmark Modafinil decision several years ago.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
